Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 376592-58-4 | MDL No. : | MFCD13184302 |
Formula : | C13H8ClNO5 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | PGNTVCRTPYDGRN-UHFFFAOYSA-N |
M.W : | 293.66 | Pubchem ID : | 21072412 |
Synonyms : |
|
Num. heavy atoms : | 20 |
Num. arom. heavy atoms : | 12 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 2.0 |
Molar Refractivity : | 74.69 |
TPSA : | 103.35 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | Yes |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.44 cm/s |
Log Po/w (iLOGP) : | 1.53 |
Log Po/w (XLOGP3) : | 3.73 |
Log Po/w (WLOGP) : | 3.32 |
Log Po/w (MLOGP) : | 2.05 |
Log Po/w (SILICOS-IT) : | 0.87 |
Consensus Log Po/w : | 2.3 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -4.26 |
Solubility : | 0.0163 mg/ml ; 0.0000554 mol/l |
Class : | Moderately soluble |
Log S (Ali) : | -5.59 |
Solubility : | 0.000751 mg/ml ; 0.00000256 mol/l |
Class : | Moderately soluble |
Log S (SILICOS-IT) : | -3.7 |
Solubility : | 0.0583 mg/ml ; 0.000199 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 2.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.4 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
86.7% | With palladium 10% on activated carbon; hydrogen; triethylamine In methanol at 20℃; for 21 h; Autoclave | [0058] 5'-Chloro-2'-hydroxy-3'-nitrobiphenyl-3-carboxylic acid (Compound 2b) (5.0 g) was dissolved in a mixture of MeOH (300 mL) and Et3N (4.75 mL). Pd/C (0.5 g) was added to the solution and the mixture was hydrogenated for 21 h at room temperature and 10 bars pressure. The catalyst was then removed by filtration, the filtrate was concentrated to dryness, and the residue was dissolved in water (40 mL). The pH was adjusted to 5.5 by dropwise addition of 0.5 M HC1 and the resulting suspension was stirred at RT for 30 min. The suspension was filtered, and the collected solid was washed with water (2 x 10 mL) and dried at 50 °C/50 mbar to provide BPCA (3.4 g; 86.7percent; HPLC purity 97.9percent). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
92% | at 20℃; for 1 h; | [0052] To a suspension of 5'-chloro-2'-hydroxybiphenyl-3-carboxylic acid (Compound 2a, 2.31 g, 9.3 mmol) in 50 percent H2S04 (15 mL) and acetic acid (120 mL) was added a solution of NaN03 (1.70 g, 20 mmol) in 25 percent H2S0 (6.5 mL). This mixture was stirred for 1 hour at room temperature, and then diluted with water (150 mL). A precipitate formed and was collected by filtration, washed with water and dried to yield compound (2b) as a greenish yellow solid (2.53 g, 92percent, purity 97percent, HPLC Method B). Ή-NMR (DMSO-d6) δ: 7.58 (t, J=7.7 Hz, 1H), 7.75-7.78 (m, 2H), 7.97 (td, J/=1.4, J2=7.7, 1H), 8.05 (d, J=2.7 Hz, 1H), 8.09 (t, J=1.5 Hz, 1H), 10.73 (s, 1H), 12.98 (s, 1H) ppm; 13C- NMR (150 MHz, DMSO-d6) δ: 123.75, 124.23, 129.22, 129.48, 130.75, 131.28, 134.21, 134.24, 135.91, 136.48, 137.80, 149.17, 167.50 ppm; MS m/z [M-H]': 292.0. |
[ 5043-79-8 ]
Methyl 5-chloro-2-hydroxy-3-nitrobenzoate
Similarity: 0.89
[ 30880-72-9 ]
3-((2-Chloro-4-nitrophenoxy)methyl)benzoic acid
Similarity: 0.80
[ 63603-09-8 ]
Methyl 4-chloro-3-methoxy-5-nitrobenzoate
Similarity: 0.78
[ 5043-79-8 ]
Methyl 5-chloro-2-hydroxy-3-nitrobenzoate
Similarity: 0.89
[ 30880-72-9 ]
3-((2-Chloro-4-nitrophenoxy)methyl)benzoic acid
Similarity: 0.80
[ 63603-09-8 ]
Methyl 4-chloro-3-methoxy-5-nitrobenzoate
Similarity: 0.78
[ 30880-72-9 ]
3-((2-Chloro-4-nitrophenoxy)methyl)benzoic acid
Similarity: 0.80
[ 5043-79-8 ]
Methyl 5-chloro-2-hydroxy-3-nitrobenzoate
Similarity: 0.89
[ 30880-72-9 ]
3-((2-Chloro-4-nitrophenoxy)methyl)benzoic acid
Similarity: 0.80
[ 63603-09-8 ]
Methyl 4-chloro-3-methoxy-5-nitrobenzoate
Similarity: 0.78